Thylakoids Reduce Body Fat and Fat Cell Size by Binding to Dietary Fat Making It Less Available for Absorption in High-fat Fed Mice

Overview

Journal Nutr Metab (Lond)

Publisher Biomed Central

Date 2017 Jan 19

PMID 28096887

Citations 3

Authors

Karin G Stenkula

Eva-Lena Stenblom

Caroline Montelius

Emil Egecioglu

Charlotte Erlanson-Albertsson

Affiliations

Soon will be listed here.

Abstract

Background: Dietary thylakoids derived from spinach have beneficial effects on body fat accumulation and blood lipids as demonstrated in humans and rodents. Important mechanisms established include delayed fat digestion in the intestine, without causing steatorrhea, and increased fatty acid oxidation in intestinal cells. The objective of our study was to elucidate if increased fecal fat excretion is an important mechanism to normalize adipose tissue metabolism during high-fat feeding in mice supplemented with thylakoids.

Methods: Mice were randomized to receive HFD or thylHFD for 14 days ( = 14 for the control group and 16 for the thylakoid group). The effect of thylakoids on body fat distribution, faecal and liver fat content, and adipose tissue metabolism was investigated following high-fat feeding.

Results: Thylakoid supplementation for 14 days caused an increased faecal fat content without compensatory eating compared to control. As a result, thylakoid treated animals had reduced fat mass depots and reduced liver fat accumulation compared to control. The size distribution of adipocytes isolated from visceral adipose tissue was narrowed and the cell size decreased. Adipocytes isolated from thylakoid-treated mice displayed a significantly increased lipogenesis, and protein expression of peroxisome proliferator-activated receptor gamma (PPARγ), down-stream target FAS, as well as transcription factor coactivators PGC1-α and LPIN-1 were upregulated in adipose tissue from thylakoid-fed mice.

Conclusions: Together, these data suggest that thylakoid supplementation reduces body fat and fat cell size by binding to dietary fat and increasing its fecal excretion, thus reducing dietary fat available for absorption.

Citing Articles

Dietary Bamboo Charcoal Decreased Visceral Adipose Tissue Weight by Enhancing Fecal Lipid Excretions in Mice with High-Fat Diet-Induced Obesity.

Sugimoto K, Shinagawa T, Kuroki K, Toma S, Hosomi R, Yoshida M Prev Nutr Food Sci. 2023; 28(3):246-254.

PMID: 37842254 PMC: 10567601. DOI: 10.3746/pnf.2023.28.3.246.

Administration of hydro-alcoholic extract of spinach improves oxidative stress and inflammation in high-fat diet-induced NAFLD rats.

Amirinejad A, Saneei Totmaj A, Mardali F, Hekmatdoost A, Emamat H, Safa M BMC Complement Med Ther. 2021; 21(1):221.

PMID: 34479550 PMC: 8418034. DOI: 10.1186/s12906-021-03396-x.

Effects of thylakoid intake on appetite and weight loss: a systematic review.

Amirinejad A, Heshmati J, Shidfar F J Diabetes Metab Disord. 2020; 19(1):565-573.

PMID: 32550209 PMC: 7270222. DOI: 10.1007/s40200-019-00443-w.

References

Eckel R, Grundy S, Zimmet P . The metabolic syndrome. Lancet. 2005; 365(9468):1415-28. DOI: 10.1016/S0140-6736(05)66378-7. View

Montelius C, Erlandsson D, Vitija E, Stenblom E, Egecioglu E, Erlanson-Albertsson C . Body weight loss, reduced urge for palatable food and increased release of GLP-1 through daily supplementation with green-plant membranes for three months in overweight women. Appetite. 2014; 81:295-304. DOI: 10.1016/j.appet.2014.06.101. View

Albertsson P, Kohnke R, Emek S, Mei J, Rehfeld J, Akerlund H . Chloroplast membranes retard fat digestion and induce satiety: effect of biological membranes on pancreatic lipase/co-lipase. Biochem J. 2006; 401(3):727-33. PMC: 1770847. DOI: 10.1042/BJ20061463. View

Bray G, Paeratakul S, Popkin B . Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiol Behav. 2004; 83(4):549-55. DOI: 10.1016/j.physbeh.2004.08.039. View

McLaughlin T, Sherman A, Tsao P, Gonzalez O, Yee G, Lamendola C . Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia. 2007; 50(8):1707-15. DOI: 10.1007/s00125-007-0708-y. View

Pittler M, Abbot N, Harkness E, Ernst E . Randomized, double-blind trial of chitosan for body weight reduction. Eur J Clin Nutr. 1999; 53(5):379-81. DOI: 10.1038/sj.ejcn.1600733. View

Finck B, Gropler M, Chen Z, Leone T, Croce M, Harris T . Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab. 2006; 4(3):199-210. DOI: 10.1016/j.cmet.2006.08.005. View

Faust I, Johnson P, Stern J, Hirsch J . Diet-induced adipocyte number increase in adult rats: a new model of obesity. Am J Physiol. 1978; 235(3):E279-86. DOI: 10.1152/ajpendo.1978.235.3.E279. View

Stenblom E, Egecioglu E, Montelius C, Ramachandran D, Bonn B, Westrom B . Dietary thylakoids reduce visceral fat mass and increase expression of genes involved in intestinal fatty acid oxidation in high-fat fed rats. Am J Physiol Regul Integr Comp Physiol. 2016; 311(3):R618-27. DOI: 10.1152/ajpregu.00212.2016. View

10.

Moody A, Stan M, Stan M, GLIEMANN J . A simple free fat cell bioassay for insulin. Horm Metab Res. 1974; 6(1):12-6. DOI: 10.1055/s-0028-1093895. View

11.

Kohnke R, Lindqvist A, Goransson N, Emek S, Albertsson P, Rehfeld J . Thylakoids suppress appetite by increasing cholecystokinin resulting in lower food intake and body weight in high-fat fed mice. Phytother Res. 2009; 23(12):1778-83. DOI: 10.1002/ptr.2855. View

12.

Kohnke R, Lindbo A, Larsson T, Lindqvist A, Rayner M, Emek S . Thylakoids promote release of the satiety hormone cholecystokinin while reducing insulin in healthy humans. Scand J Gastroenterol. 2009; 44(6):712-9. DOI: 10.1080/00365520902803499. View

13.

Montelius C, Osman N, Westrom B, Ahrne S, Molin G, Albertsson P . Feeding spinach thylakoids to rats modulates the gut microbiota, decreases food intake and affects the insulin response. J Nutr Sci. 2014; 2:e20. PMC: 4153289. DOI: 10.1017/jns.2012.29. View

14.

Wang L, Waltenberger B, Pferschy-Wenzig E, Blunder M, Liu X, Malainer C . Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochem Pharmacol. 2014; 92(1):73-89. PMC: 4212005. DOI: 10.1016/j.bcp.2014.07.018. View

15.

Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner A . Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth. PLoS Comput Biol. 2009; 5(3):e1000324. PMC: 2653640. DOI: 10.1371/journal.pcbi.1000324. View

16.

Cecil J, Watt P, Palmer C, Hetherington M . Energy balance and food intake: the role of PPARgamma gene polymorphisms. Physiol Behav. 2006; 88(3):227-33. DOI: 10.1016/j.physbeh.2006.05.028. View

17.

Guerciolini R, Boldrin M, Dallas J, MOORE R . Comparative evaluation of fecal fat excretion induced by orlistat and chitosan. Obes Res. 2001; 9(6):364-7. DOI: 10.1038/oby.2001.47. View

18.

Hebert J, Allison D, Archer E, Lavie C, Blair S . Scientific decision making, policy decisions, and the obesity pandemic. Mayo Clin Proc. 2013; 88(6):593-604. PMC: 3759398. DOI: 10.1016/j.mayocp.2013.04.005. View

19.

Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar H . Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet. 1998; 352(9123):167-72. DOI: 10.1016/s0140-6736(97)11509-4. View

20.

Emek S, Szilagyi A, Akerlund H, Albertsson P, Kohnke R, Holm A . A large scale method for preparation of plant thylakoids for use in body weight regulation. Prep Biochem Biotechnol. 2009; 40(1):13-27. DOI: 10.1080/10826060903413057. View